Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: Harold Engstrom who wrote (1128)	9/15/1999 5:45:00 PM
From: William Partmann	Read Replies (2) \| Respond to of 1686

Biogen sees Q3 above street's projections CAMBRIDGE, Mass., Sept 15 (Reuters) - Pharmaceutical company Biogen Inc. on Wednesday said it expects third-quarter earnings to be about $0.38 per share and revenues to be higher than expected because of continued growth in prescriptions for its multiple sclerosis drug Avonex. Analysts had expected the Biogen to earn $0.36 per share in the third quarter, according to First Call/Thomson. Third-quarter sales for Avonex are expected to reach about $160 million, the company said. Biogen's Avonex (Interferon beta-1a) is the world's leading therapy for treatment of relapsing forms of multiple sclerosis. Shares of Biogen Wednesday closed down 3-1/4 to 84-1/8 on the Nasdaq stock market before the news of the earnings projections was released.

To: Harold Engstrom who wrote (1128)	9/15/1999 11:36:00 PM
From: Vector1	Respond to of 1686

Harold, We should rock tomorrow: cbs.marketwatch.com v1

To: Harold Engstrom who wrote (1128)	10/5/1999 2:58:00 PM
From: Beltropolis Boy	Respond to of 1686

expansion afoot. "Joining Jim Vincent as speakers at the groundbreaking were Senator Edward M. Kennedy, Cambridge Mayor Francis Duehay, Director of the Massachusetts Department of Economic Development Carolyn Boviard, and Jacqueline Sullivan, chair of the Cambridge Redevelopment Authority." i wonder if the labcoats cooked up a special batch of jello-shooter cocktails for uncle ted. ----- Biogen Establishes Nordic Operations PR Newswire - October 04, 1999 12:36 marketwatch.newsalert.com Biogen Breaks Ground for New R&D Center in Cambridge PR Newswire - October 04, 1999 12:11 marketwatch.newsalert.com